Adenuric (febuxostat) 80mg and 120mg tablets are indicated for the treatment of chronic hyperuricaemia for conditions in which urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).
Adenuric will be marketed by Ipsen in France. Outside France, the commercialization of the product will be partnered.